TECOGEN INC. registered up to 4,507,603 common shares for resale by selling stockholders. The holders, or permitted successors, may sell through brokers, dealers, underwriters or negotiated transactions, while TECOGEN receives no proceeds from those sales, a direct consideration for investors assessing the offering.
Key Highlights
- TECOGEN will receive no proceeds from sales of the registered shares.
- The prospectus identifies a $5.00 per-share price for an earlier underwritten public offering that included 485,000 over-allotment shares.
- Trust shares are subject to a 182-calendar-day lockup after registration effectiveness, subject to limited exceptions.
TECOGEN INC. (AMEX: TGEN) registered up to 4,507,603 common shares for resale by selling stockholders. The holders may offer the shares through brokers, dealers, underwriters or privately negotiated transactions, while TECOGEN will receive no proceeds from those sales.
Resale Terms Cover 4,507,603 Common Shares
The company said the shares may be sold in one or more offerings up to the stated total. TECOGEN’s authorized Capital includes 100,000,000 common shares and 10,000,000 preferred shares.
Trust Lockup Runs 182 Calendar Days
Michael Bass serves as Trustee for both trusts under the lockup arrangement. As of August 28, 2026, TECOGEN had 30,187,822 common shares issued and outstanding. The prospectus also references an earlier underwritten public offering priced at $5.00 per share, including an additional 485,000 shares for over-allotments. Net proceeds from that offering were approximately $18,105,100, while proceeds from the resale covered here go directly to the selling stockholders.




Please wait processing your request...